Nuvalent, Inc.(NUVL)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-11 | Noci Darlene Chief Development Officer | Sale | -20,000 | -25.60%58,117 | $122.81 | $2,456,200 | View SEC filing | |
| 2026-06-10 | Porter James Richard President and CEO | Sale | -30,000 | -8.45%324,879 | $88.53 | $2,656,004 | View SEC filing | |
| 2026-06-03 | Balcom Alexandra Chief Financial Officer | Sale | -11,430 | -11.79%85,533 | $98.69 | $1,128,080 | View SEC filing | |
| 2026-06-01 | Miller Deborah Ann Chief Legal Officer | Sale | -5,500 | -8.44%59,634 | $107.84 | $593,101 | View SEC filing | |
| 2026-06-01 | Noci Darlene Chief Development Officer | Sale | -5,500 | -8.65%58,117 | $107.80 | $592,923 | View SEC filing | |
| 2026-05-06 | Porter James Richard President and CEO | Sale | -30,000 | -8.45%324,879 | $101.69 | $3,050,712 | View SEC filing | |
| 2026-05-05 | Balcom Alexandra Chief Financial Officer | Sale | -11,430 | -11.79%85,533 | $99.00 | $1,131,600 | View SEC filing | |
| 2026-05-01 | Miller Deborah Ann Chief Legal Officer | Sale | -5,500 | -8.44%59,634 | $99.22 | $545,691 | View SEC filing | |
| 2026-05-01 | Noci Darlene Chief Development Officer | Sale | -5,500 | -8.65%58,117 | $99.55 | $547,524 | View SEC filing | |
| 2026-04-13 | Pelish Henry E. Chief Scientific Officer | Sale | -3,093 | -4.50%65,604 | $104.48 | $323,164 | View SEC filing | |
| 2026-04-08 | Porter James Richard President and CEO | Sale | -30,000 | -8.45%324,879 | $103.77 | $3,113,231 | View SEC filing | |
| 2026-04-03 | Balcom Alexandra Chief Financial Officer | Sale | -11,430 | -11.79%85,533 | $105.21 | $1,202,527 | View SEC filing | |
| 2026-04-01 | Noci Darlene Chief Development Officer | Sale | -5,500 | -8.65%58,117 | $97.81 | $537,943 | View SEC filing | |
| 2026-03-30 | Miller Deborah Ann Chief Legal Officer | Sale | -5,500 | -8.44%59,634 | $98.73 | $542,991 | View SEC filing | |
| 2026-03-26 | Balcom Alexandra Chief Financial Officer | Sale | -25,130 | -22.71%85,533 | $98.15 | $2,466,610 | View SEC filing | |
| 2026-03-16 | Pelish Henry E. Chief Scientific Officer | Sale | -35,104 | -34.86%65,604 | $98.08 | $3,442,856 | View SEC filing | |
| 2026-03-10 | Porter James Richard President and CEO | Sale | -30,000 | -8.45%324,879 | $98.99 | $2,969,551 | View SEC filing | |
| 2026-03-02 | Noci Darlene Chief Development Officer | Sale | -5,500 | -8.65%58,117 | $103.03 | $566,682 | View SEC filing | |
| 2026-03-02 | Miller Deborah Ann Chief Legal Officer | Sale | -5,500 | -8.44%59,634 | $103.05 | $566,788 | View SEC filing | |
| 2026-02-02 | Noci Darlene Chief Development Officer | Sale | -5,500 | -8.65%58,117 | $102.08 | $561,422 | View SEC filing | |
| 2026-01-23 | Miller Deborah Ann Chief Legal Officer | Sale | -15,000 | -1.16%59,634 | $110.15 | $1,652,176 | View SEC filing | |
| 2026-01-07 | Pelish Henry E. Chief Scientific Officer | Sale | -5,160 | -7.26%65,888 | $97.24 | $501,753 | View SEC filing | |
| 2026-01-07 | Noci Darlene Chief Development Officer | Sale | -7,417 | -15.44%40,617 | $97.25 | $721,320 | View SEC filing | |
| 2026-01-07 | Miller Deborah Ann Chief Legal Officer | Sale | -6,952 | -14.16%42,134 | $97.26 | $676,158 | View SEC filing | |
| 2026-01-07 | Turner Christopher Durant Chief Medical Officer | Sale | -7,417 | -11.86%55,130 | $97.25 | $721,320 | View SEC filing |
1-25 of 192